Bicycle Therapeutics plc (BCYC): Price and Financial Metrics
BCYC Price/Volume Stats
| Current price | $9.79 | 52-week high | $28.67 |
| Prev. close | $10.23 | 52-week low | $9.58 |
| Day low | $9.58 | Volume | 340,100 |
| Day high | $10.15 | Avg. volume | 299,773 |
| 50-day MA | $12.76 | Dividend yield | N/A |
| 200-day MA | $20.06 | Market Cap | 675.96M |
BCYC Stock Price Chart Interactive Chart >
Bicycle Therapeutics plc (BCYC) Company Bio
Bicycle Therapeutics Plc is a holding company, which engages in the development of biopharmaceuticals. It focuses on developing a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. The firm utilizes its novel and proprietary phage display screening platform to identify bicycles. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.
BCYC Price Returns
| 1-mo | -19.62% |
| 3-mo | -53.58% |
| 6-mo | -64.06% |
| 1-year | -58.64% |
| 3-year | -77.95% |
| 5-year | -38.85% |
| YTD | -30.07% |
| 2024 | -22.57% |
| 2023 | -38.92% |
| 2022 | -51.37% |
| 2021 | 239.11% |
| 2020 | 90.35% |
Loading social stream, please wait...